1. Low molecular weight IgM in rheumatoid arthritis and other different levels of CD5 B cells have been found in the same patient's sample.37 As such, more sensitive techniques have resulted in smaller differences in the proportions of CD5 B cells in RA and normal controls. Our data showed the levels of CD5 B cells in the PB of patients with RA and other inflammatory arthritides were stable over time rheumatic diseases;J, Roberts-Thomson P.; M, Wernick R.; M, Ziff;Arthritis Rheum,1981
2. Low molecular weight IgM: detection using immunoblotting;Harris, R.; Beckman, I.; Roberts-Thomson;J Immunol Methods,1986
3. Circulating low molecular weight IgM-A disease marker in autoimmune, infective, immunodeficient and B cell lymphoproliferative disorders;J, Xu H.; J, Roberts-Thomson P.;Disease Markers,1992
4. Clinical significance of low molecular weight IgM in patients with systemic lupus erythematous;Harisdangkul, V.; Y, Barnes T.; Sogcharoen, S.; B, Pennebaker J.;J Rheumatol; This finding has been supported by other investigations.'6 38 39 The exception was,1984
5. Monomeric (7s) IgM in chronic liver diseases. Clin Exp Imnmunol 1979; 38: 204-10. patients treated with high-dose corticosteroids or combined immunosuppressive chemotherapy and irradiation.'6 39 However, there appears to be no clear correlation between the;M, Fakunle Y.; F, Aranguibel; D, DeViliers; C, Thomas H.; S, Slerlock